Skip to content

Cellobiose Effect On the Intestinal Glucose Absorption

The Effect Of Cellobiose In the Reduction Of Intestinal Glucose Absorption In Patients With Impaired Glucose Tolerance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014052617851N1
Enrollment
20
Registered
2016-12-02
Start date
2016-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-diabetes. Abnormal glucose tolerance test

Interventions

Intervention 1: Control group: In this step volunteers do oral glucose tolerance test according to American Diabetes Association's(ADA) instruction. Intervention 2: Intervention group: In this step vo
Diagnosis
Treatment - Drugs
Control group: In this step volunteers do oral glucose tolerance test according to American Diabetes Association's(ADA) instruction.
Intervention group: In this step volunteers take 30g cellobiose during oral glucose tolerance test in addition to glucose administration, simultaneously.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients in pre-diabetes stage or impaired glucose tolerance via convenience method are included. Exclusion Criteria : Age >60 or age <18 ; Overt diabetes (type 1/ type 2) ; Consumption of any anti diabetic drug ; Poor cooperation ; Malignancy ; Pregnancy and lactation ; Chronic liver diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood glucose level. Timepoint: At time 0 and then 1 and 2 and 3 hours after oral glucose tolerance test. Method of measurement: variable unit of measurement:mg/dl method of measuring: Venesection.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Maleknasab

Shiraz University of Medical Science, School of Pharmacy

maleknasab@sums.ac.ir mahmoudi_l@sums.ac.ir+98 71 3843 6769

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026